Clinical aspects of adherence to pharmacotherapy in Parkinson disease: A PRISMA-compliant systematic review.

about

Clinical aspects of adherence to pharmacotherapy in Parkinson disease: A PRISMA-compliant systematic review.

Item

http://www.wikidata.org/entity/Q55209544

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Clinical aspects of adherence ...... A-compliant systematic review.

@en

Clinical aspects of adherence ...... A-compliant systematic review.

@nl

type

Item

label

Clinical aspects of adherence ...... A-compliant systematic review.

@en

Clinical aspects of adherence ...... A-compliant systematic review.

@nl

altLabel

Clinical aspects of adherence to pharmacotherapy in Parkinson disease

@en

prefLabel

Clinical aspects of adherence ...... A-compliant systematic review.

@en

Clinical aspects of adherence ...... A-compliant systematic review.

@nl

P1476

Clinical aspects of adherence ...... MA-compliant systematic review

@en

P2093

Andrea Gažová

http://www.w3.org/2001/XMLSchema#string

Igor Straka

http://www.w3.org/2001/XMLSchema#string

Michal Minár

http://www.w3.org/2001/XMLSchema#string

Peter Valkovič

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Cognitive Training in Parkinson's Disease: A Review of Studies from 2000 to 2014

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

Impact of medication therapy discontinuation on mortality after myocardial infarction

Adherence to Medication

A systematic review of the associations between dose regimens and medication compliance.

Interventions to enhance patient adherence to medication prescriptions: scientific review.

Effect of educational intervention on medication timing in Parkinson's disease: a randomized controlled trial

Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease.

Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence.

Possible extrapyramidal system degradation in Parkinson's disease.

P304

e10962

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0000000000010962

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jan Kyselovic

P5008

ScienceSource

P577

2018-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29879046

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

pharmacotherapy

P932

5999496

http://www.w3.org/2001/XMLSchema#string